Results summary | View all lists in L2L MDB | View all genes in N05AL.profile.d50 |
Down-regulated following treatment with Et-743 at any timepoint in at least 8 of 11 sarcoma cell lines enrichment: 4.41-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
218401_S_AT | ZNF281 | R | ![]() |
![]() |
zinc finger protein 281 | ||||||||
215886_X_AT | USP12 | P | ![]() |
![]() |
ubiquitin specific peptidase 12 | ||||||||
210317_S_AT | YWHAE | S | ![]() |
![]() |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | ||||||||
211084_X_AT | PRKD3 | P | S | ![]() |
![]() |
protein kinase D3 | |||||||
207563_S_AT | OGT | P | S | ![]() |
![]() |
O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase) |